The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Sensory Nerves May Be Key for Osteoporosis

Sensory Nerves May Be Key for Osteoporosis

September 10, 2013 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

For the first time, investigators demonstrate that sensory nerves have an essential role in bone remodeling. In particular, semaphorin 3A (Sema3A) regulates bone remodeling by modulating sensory nerve development. It does this without directly acting on osteoblasts.

You Might Also Like
  • Orexin’s Yin/Yang Functions Regulate Bone Remodeling
  • SIRT1: A Therapeutic Target for Osteoporosis?
  • Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium
Also By This Author
  • Patients with Active RA Have Higher Drug Efflux Transporter Activity

Toru Fukuda and colleagues from Keio University in Tokyo published the results of their knockout mouse study in Nature.1 Their research in bone remodeling builds on their earlier demonstration that Sema3A is critical for the normal development of sensory neurons in vivo. They have previously shown that Sema3A knockout mice exhibit neuronal abnormalities such as problems with olfactory development.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The current study was designed to address the role of Sema3A in bone remodeling. To that end, the investigators created four additional strains of mice. They created two strains of mice that were osteoblast-specific Sema3A-deficient (Sema3acol1-/- and Sema3aosx-/-) and found that these mice have normal bone mass despite the substantial decrease of Sema3A in bone.

The authors also created two strains of mice that were neuron-specific Sema3A-deficient (Sema3asynapsin-/- and Sema3anestin -/-). These mice have the low bone mass that is characteristic of the Sema3a-/- mice. The difference between the mouse strains suggests that neuron-derived and not bone-derived Sema3A is responsible for the bone abnormalities.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Sema3asynapsin-/- and Sema3anestin-/- mice exhibit the same abnormal neuronal development as that seen in the Sema3a-/- mice, indicating that the Sema3A produced by neurons regulates neuronal development in an autocrine manner. The authors also found that Sema3asynapsin-/– mice had significantly fewer sensory innervations of trabecular bone. In contrast, sympathetic innervations of trabecular bone were unchanged in these mice.

When the investigators ablated sensory nerves in wild-type mice, they were able to decrease bone mass. In contrast, ablation did not reduce the low bone mass seen in Sema3anestin-/- mice any further.

“These results demonstrate an essential role of sensory nerves in bone metabolism,” wrote coauthor Shu Takeda, MD, PhD, of Keio University in an e-mail to The Rheumatologist. The authors proposed in their paper that Sema3A does this by modulating sensory nerve projections into the bone.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

When asked about the implications for weight-bearing exercise, Dr. Takeda responded: “It is possible that weight-bearing exercise increases bone formation by affecting sensory nerves, as you may hypothesize. Currently there is no experimental evidence, but it is under investigation.”


Dr. Pullen is a medical writer based in the Chicago area.

Reference

  1. Fukuda T, Takeda S, Xu R, et al. Sema3A regulates bone-mass accrual through sensory innervations. Nature. 2013;497:490-493.

Pages: 1 2 | Single Page

Filed Under: Conditions, Research Reviews Tagged With: Osteoporosis, Sema3A, semaphorin, sensory nerves

You Might Also Like:
  • Orexin’s Yin/Yang Functions Regulate Bone Remodeling
  • SIRT1: A Therapeutic Target for Osteoporosis?
  • Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium
  • 2015 ACR/ARHP Annual Meeting: Therapies that Target Schnurri-3 Hold Promise for Osteoporosis

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)